A new multi-parameter flow cytometric assay for monitoring lymphoma growth and spread in a pre-clinical murine model for human lymphoma

Cytometry. Part a : the Journal of the International Society for Analytical Cytology
P Neeson, Y Paterson

Abstract

Mouse survival is commonly used as an indirect measure of lymphoma tumor response to anti-idiotype vaccine; however, this gives no information regarding residual lymphoma cells at primary or metastatic sites. We aimed to develop a method with which to monitor lymphoma tumor kinetics in the mouse as an independent measure of vaccine efficacy. We developed a multi-parameter flow cytometric (MPFC) assay for 38C13 mouse lymphoma cells using sequential gating to detect aberrant antigen expression and binding by an anti-idiotype antibody (S1C5). Subsequently, we tested the utility of the MPFC assay in a 38C13 tumor modeling study in the C3H/HeN mouse. The MPFC assay was demonstrated in vitro to have both high specificity and sensitivity for 38C13 lymphoma cells. In tumor kinetic studies in the C3H/HeN mouse, as the tumor enlarged, the MPFC assay showed increasing prevalence of 38C13 cells at the inoculation site in addition to metastases to lymphoid organs and bone marrow. The latter findings were confirmed by both histology and immunohistochemistry. The MPFC assay is an independent parameter for monitoring 38C13 lymphoma kinetics and could be used to monitor tumor response to individual vaccines or other lymphoma therapy prior to cl...Continue Reading

References

Jul 1, 1977·European Journal of Immunology·Y Bergman, J Haimovich
Aug 1, 1977·European Journal of Immunology·Y BergmanF Melchers
Jan 1, 1991·Cellular Immunology·R J DykeF K Stevenson
May 1, 1993·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A JohnsonH Anderson
Sep 1, 1996·Nature Medicine·A D SyrengelasR Levy
Jan 20, 1999·Proceedings of the National Academy of Sciences of the United States of America·A A McCormickR Levy
Apr 26, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J M Timmerman, R Levy
Jul 6, 2000·The Journal of Immunology : Official Journal of the American Association of Immunologists·J MaësM Goodhardt
Sep 7, 2000·The Journal of Experimental Medicine·M J SmythJ A Trapani
Nov 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·A BiragynL W Kwak
Dec 26, 2001·Experimental Hematology·J HardyC H Contag
Jan 23, 2002·Immunology Letters·Alina HeyfetsNurit Hollander
Mar 1, 2002·Current Opinion in Immunology·Mark J SmythDale I Godfrey
Apr 9, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Anne C ArmstrongRobert E Hawkins
Jul 3, 2002·The Journal of Experimental Medicine·Shayna E A StreetMark J Smyth
Oct 31, 2002·Nature Immunology·Gavin P DunnRobert D Schreiber
Dec 4, 2002·Nature Cell Biology·Elisa de Stanchina, Scott W Lowe

❮ Previous
Next ❯

Citations

Apr 3, 2008·Cytometry. Part a : the Journal of the International Society for Analytical Cytology·Wade T RogersJonni S Moore

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Related Papers

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
K A FoonM Bhattacharya-Chatterjee
The Journal of Immunology : Official Journal of the American Association of Immunologists
A HatzubaiR Levy
Journal of the National Cancer Institute. Monographs
R Levy, R A Miller
© 2022 Meta ULC. All rights reserved